Recovery and survival in vivo of platelet concentrates prepared with prostaglandin E1
- 2 January 1988
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 28 (1) , 56-58
- https://doi.org/10.1046/j.1537-2995.1988.28188127954.x
Abstract
In follow-up to previous studies showing that stimulators of adenylate cyclase inhibit the activation of platelets in platelet concentrates (PC), the posttransfusion recovery and survival of autologous platelets prepared and stored after the addition of prostaglandin E1 (PGE1) to platelet-rich plasma at a concentration of 1.3 .times. 10-8 M were investigated. Six normal subjects were studied on the two occasions, using PC stored with and without PGE1 and radiolabeling with 51Cr. The mean recovery of platelets prepared with PGE1 (35.2 .+-. 8.1%) was significantly lower (p < 0.013) than that of routinely prepared platelet concentrates (46.3 .+-. 9.4%). The mean life-spans of platelets prepared with and without PGE1 were 7.1 .+-. 0.4 and 6.2 .+-. 1.0 days, respectively (p = NS). Despite its ability to inhibit the activation of platelets during concentration and storage, prostaglandin E1 appears to reduce posttransfusion recovery of platelets significantly in this experimental model and cannot be recommended at this time as an adjunct for PC preparation.This publication has 23 references indexed in Scilit:
- Studies of the minimum temperature at which human platelets can be stored with full maintenance of viabilityTransfusion, 1986
- Use of PGE1 for preparation of platelet concentratesTransfusion, 1986
- Platelet storage for 7 days in second‐generation blood bagsTransfusion, 1986
- Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.Journal of Clinical Investigation, 1985
- Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentratesTransfusion, 1984
- Five‐day storage of platelet concentratesTransfusion, 1984
- Long-term prostaglandin E1therapy in congenital heart defectsJournal of the American College of Cardiology, 1984
- Extension of platelet concentrate storageTransfusion, 1983
- Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic AgentNew England Journal of Medicine, 1981
- PROSTACYCLIN ADMINISTRATION DURING CARDIOPULMONARY BYPASS IN MANThe Lancet, 1981